Investment Column: Investors will get security with G4S stock

Tullett Prebon; Axis-Shield

Our view: Buy

Share price: 187.8p (+11.3p)

The casual reader of the business pages of any newspaper may be forgiven for thinking that it is all doom and gloom out there. G4S, the FTSE 100-listed group that specialises in security services, would beg to differ.

True, the company wheels out the same hackneyed nonsense about being "recession resilient," rather than sticking its neck out and admitting it is having a whale of a time, but its full-year numbers, published yesterday, do show that despite the economic malaise, the group is going great guns.

G4S reported a rise of 23 per cent in full-year earnings. More importantly for investors, the shares closed the day up 6.4 per cent, and the all important dividend is up 29 per cent. Despite revenue growth slowing in the fourth quarter, which punters should view as a concern, the company is confident that 2009 will be another bumper year, driven by more outsourcing deals.

So is there a bear case? Well, the shares have traded down in the past year, but they have done so by less than the market average. What's more, as a result of recent softening, the stock is inexpensive, trading at 10 times 2010 earnings, according to analysts at Killik Capital. Those at Cazenove offer that trading on a 2009 price-earnings ratio of 8.6 times, G4S comes at a discount to rival Securitas, which has said in recent weeks that it is starting to feel the recessionary pinch.

G4S's business is essentially an outsourcing one, and by claiming that it can save clients' money, it has obvious benefits in these markets. A move to doing more government-related work is a plus, and the fact that the company does 70 per cent of its work in areas other than the UK, US and northern European, where the group admits some of its clients are going bust, also helps. We think G4S is one of the better stocks available. Buy.

Tullett Prebon

Our view: Hold

Share price: 171.5p (+35.25p)

Investors have not thought that much of the inter-dealer broker Tullett Prebon in the past year, and were it not for other stocks doing very badly indeed, the firm's annual share price drop of 70 per cent before yesterday would look disastrous.

The company, which operates in various markets, including fixed income, rates and energy securities, gave investors reason for serious cheer yesterday, however, posting a stellar 36 per cent rise in full-year pre-tax profits that sent the shares up 26 per cent: the best performance by a FTSE 250 company.

Investors face something of a dilemma. The group is performing well, and clearly the downturn, which was first apparent in the financial markets, is having a limited effect, especially with the group thriving on the market volatility. The market is not giving the company credit for this performance, however, and the share price remains poor.

One persuading factor could be the group's share price, which, according to Evolution, "on four times our 2009 [earnings per share] estimate the stock is cheap". The analysts are somewhat divided, however, and those at Panmure Gordon warn that "the statement gives no catalyst for a re-rating, while major structural concerns continue to overhang the shares. The outlook lacks substance, earnings visibility continues to be poor and revenues are reported to have slowed in the first few months of 2009".

We are impressed by the numbers, and accept the volatility argument. But whether the market will continue to back the group after yesterday's results remains uncertain, and we would wait to see if investors stay supportive. Hold.


Our view: Buy

Share price: 295p (+2.5p)

Regular readers of this column will be well aware that the biotechnology sector has not been flavour of the past year or so with investors. Too many groups have relied on the old model of burning through vast quantities of cash before going cap-in-hand to backers who have understandably tired of the whole thing.

Thankfully, the diagnostics group Axis-Shield is not one of these groups, and it has been well rewarded by the market, with its shares up by more than 10 per cent in the past year. Yesterday, the group issued its full-year results, saying that despite a pre-tax loss of £4.3m, revenues were up 27.8 per cent, and the group is confident of double-digit growth in 2009. The loss included exceptional items, without which 2008 was a profitable year.

The chief executive, Ian Gilham, says the company, which specialises in devices that save the need for sending tests off to laboratories, will benefit as healthcare providers look to save costs on other expensive diagnostics procedures, and that its primary device will add another 2,500 sales this year.

Shares in the biotech market tend to move on news, good or bad. We reckon that Axis-Shield is likely to have more good news than bad this year. Buy.

Suggested Topics
Start your day with The Independent, sign up for daily news emails
Arts and Entertainment
Lou Reed distorted the truth about his upbringing, and since his death in 2013, biographers and memoirists have added to the myths
musicThe truth about Lou Reed's upbringing beyond the biographers' and memoirists' myths
Ed Miliband received a warm welcome in Chester
election 2015
Life and Style
Apple CEO Tim Cook announces the Apple Watch during an Apple special even
fashionIs the Apple Watch for you? Well, it depends if you want it for the fitness tech, or for the style
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45,000: SThree: SThree Group have been well e...

Ashdown Group: IT Manager / Development Manager - NW London - £58k + 15% bonus

£50000 - £667000 per annum + excellent benefits : Ashdown Group: IT Manager / ...

Recruitment Genius: Sales Consultant / Telemarketer - OTE £20,000

£13000 - £20000 per annum: Recruitment Genius: Scotland's leading life insuran...

Ashdown Group: Training Programme Manager - City, London

£40000 - £45000 per annum + benefits : Ashdown Group: Training Programme Manag...

Day In a Page

Armenian genocide: To continue to deny the truth of this mass human cruelty is close to a criminal lie

Armenian genocide and the 'good Turks'

To continue to deny the truth of this mass human cruelty is close to a criminal lie
Lou Reed: The truth about the singer's upbringing beyond the biographers' and memoirists' myths

'Lou needed care, but what he got was ECT'

The truth about the singer's upbringing beyond
Migrant boat disaster: This human tragedy has been brewing for four years and EU states can't say they were not warned

This human tragedy has been brewing for years

EU states can't say they were not warned
Women's sportswear: From tackling a marathon to a jog in the park, the right kit can help

Women's sportswear

From tackling a marathon to a jog in the park, the right kit can help
Hillary Clinton's outfits will be as important as her policies in her presidential bid

Clinton's clothes

Like it or not, her outfits will be as important as her policies
NHS struggling to monitor the safety and efficacy of its services outsourced to private providers

Who's monitoring the outsourced NHS services?

A report finds that private firms are not being properly assessed for their quality of care
Zac Goldsmith: 'I'll trigger a by-election over Heathrow'

Zac Goldsmith: 'I'll trigger a by-election over Heathrow'

The Tory MP said he did not want to stand again unless his party's manifesto ruled out a third runway. But he's doing so. Watch this space
How do Greek voters feel about Syriza's backtracking on its anti-austerity pledge?

How do Greeks feel about Syriza?

Five voters from different backgrounds tell us what they expect from Syriza's charismatic leader Alexis Tsipras
From Iraq to Libya and Syria: The wars that come back to haunt us

The wars that come back to haunt us

David Cameron should not escape blame for his role in conflicts that are still raging, argues Patrick Cockburn
Sam Baker and Lauren Laverne: Too busy to surf? Head to The Pool

Too busy to surf? Head to The Pool

A new website is trying to declutter the internet to help busy women. Holly Williams meets the founders
Heston Blumenthal to cook up a spice odyssey for British astronaut manning the International Space Station

UK's Major Tum to blast off on a spice odyssey

Nothing but the best for British astronaut as chef Heston Blumenthal cooks up his rations
John Harrison's 'longitude' clock sets new record - 300 years on

‘Longitude’ clock sets new record - 300 years on

Greenwich horologists celebrate as it keeps to within a second of real time over a 100-day test
Fears in the US of being outgunned in the vital propaganda wars by Russia, China - and even Isis - have prompted a rethink on overseas broadcasters

Let the propaganda wars begin - again

'Accurate, objective, comprehensive': that was Voice of America's creed, but now its masters want it to promote US policy, reports Rupert Cornwell
Why Japan's incredible long-distance runners will never win the London Marathon

Japan's incredible long-distance runners

Every year, Japanese long-distance runners post some of the world's fastest times – yet, come next weekend, not a single elite competitor from the country will be at the London Marathon
Why does Tom Drury remain the greatest writer you've never heard of?

Tom Drury: The quiet American

His debut was considered one of the finest novels of the past 50 years, and he is every bit the equal of his contemporaries, Jonathan Franzen, Dave Eggers and David Foster Wallace